EP4127043A1 - Verbundstoff aus bor bei der herstellung eines polyurethanbasismaterials - Google Patents

Verbundstoff aus bor bei der herstellung eines polyurethanbasismaterials

Info

Publication number
EP4127043A1
EP4127043A1 EP20735248.5A EP20735248A EP4127043A1 EP 4127043 A1 EP4127043 A1 EP 4127043A1 EP 20735248 A EP20735248 A EP 20735248A EP 4127043 A1 EP4127043 A1 EP 4127043A1
Authority
EP
European Patent Office
Prior art keywords
weight
composite material
boron compound
polyurethane
base material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20735248.5A
Other languages
English (en)
French (fr)
Inventor
Emir TEM ZKAN
Gülden ERO LU
Hüseyin DEL GÖZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Safas Saf Plastik Sanayi Ve Ticaret AS
Original Assignee
Safas Saf Plastik Sanayi Ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Safas Saf Plastik Sanayi Ve Ticaret AS filed Critical Safas Saf Plastik Sanayi Ve Ticaret AS
Publication of EP4127043A1 publication Critical patent/EP4127043A1/de
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/0066Use of inorganic compounding ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/425Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/46Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/08Processes
    • C08G18/16Catalysts
    • C08G18/18Catalysts containing secondary or tertiary amines or salts thereof
    • C08G18/20Heterocyclic amines; Salts thereof
    • C08G18/2045Heterocyclic amines; Salts thereof containing condensed heterocyclic rings
    • C08G18/2063Heterocyclic amines; Salts thereof containing condensed heterocyclic rings having two nitrogen atoms in the condensed ring system
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/08Processes
    • C08G18/16Catalysts
    • C08G18/22Catalysts containing metal compounds
    • C08G18/24Catalysts containing metal compounds of tin
    • C08G18/244Catalysts containing metal compounds of tin tin salts of carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/30Low-molecular-weight compounds
    • C08G18/32Polyhydroxy compounds; Polyamines; Hydroxyamines
    • C08G18/3271Hydroxyamines
    • C08G18/3275Hydroxyamines containing two hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/30Low-molecular-weight compounds
    • C08G18/32Polyhydroxy compounds; Polyamines; Hydroxyamines
    • C08G18/3271Hydroxyamines
    • C08G18/3278Hydroxyamines containing at least three hydroxy groups
    • C08G18/3281Hydroxyamines containing at least three hydroxy groups containing three hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/65Low-molecular-weight compounds having active hydrogen with high-molecular-weight compounds having active hydrogen
    • C08G18/66Compounds of groups C08G18/42, C08G18/48, or C08G18/52
    • C08G18/6666Compounds of group C08G18/48 or C08G18/52
    • C08G18/667Compounds of group C08G18/48 or C08G18/52 with compounds of group C08G18/32 or polyamines of C08G18/38
    • C08G18/6681Compounds of group C08G18/48 or C08G18/52 with compounds of group C08G18/32 or polyamines of C08G18/38 with compounds of group C08G18/32 or C08G18/3271 and/or polyamines of C08G18/38
    • C08G18/6688Compounds of group C08G18/48 or C08G18/52 with compounds of group C08G18/32 or polyamines of C08G18/38 with compounds of group C08G18/32 or C08G18/3271 and/or polyamines of C08G18/38 with compounds of group C08G18/3271
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/70Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
    • C08G18/72Polyisocyanates or polyisothiocyanates
    • C08G18/74Polyisocyanates or polyisothiocyanates cyclic
    • C08G18/76Polyisocyanates or polyisothiocyanates cyclic aromatic
    • C08G18/7614Polyisocyanates or polyisothiocyanates cyclic aromatic containing only one aromatic ring
    • C08G18/7621Polyisocyanates or polyisothiocyanates cyclic aromatic containing only one aromatic ring being toluene diisocyanate including isomer mixtures
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/04Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent
    • C08J9/12Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a physical blowing agent
    • C08J9/14Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a physical blowing agent organic
    • C08J9/143Halogen containing compounds
    • C08J9/144Halogen containing compounds containing carbon, halogen and hydrogen only
    • C08J9/145Halogen containing compounds containing carbon, halogen and hydrogen only only chlorine as halogen atoms
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/38Boron-containing compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2101/00Manufacture of cellular products
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2110/00Foam properties
    • C08G2110/0083Foam properties prepared using water as the sole blowing agent
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2203/00Foams characterized by the expanding agent
    • C08J2203/14Saturated hydrocarbons, e.g. butane; Unspecified hydrocarbons
    • C08J2203/142Halogenated saturated hydrocarbons, e.g. H3C-CF3
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2207/00Foams characterised by their intended use
    • C08J2207/10Medical applications, e.g. biocompatible scaffolds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2207/00Foams characterised by their intended use
    • C08J2207/12Sanitary use, e.g. diapers, napkins or bandages
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2375/00Characterised by the use of polyureas or polyurethanes; Derivatives of such polymers
    • C08J2375/04Polyurethanes
    • C08J2375/08Polyurethanes from polyethers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/38Boron-containing compounds
    • C08K2003/387Borates

Definitions

  • the invention relates to a composite material formed by using boron during production of a polyurethane base material.
  • wound healing materials produced using Boron are available, which materials are obtained by adding boron to the structures such as collagen, hydrogel. Wound healing materials formed by adding Boron to a polyurethane material are not included in the state of the art.
  • the patent document no. TR 2019/12225 discloses polyurethane foam produced for hygiene.
  • the amount of boron added to the foam contains 10% borax.
  • Said patent document disclosed a composite material obtained by adding 9-35% boron compound to a polyol during polyurethane production. Therefore, the ratio of the boron compound in the composite material is provided to be 5-23%. Said patent document does not disclose the wound healing property of the composite material.
  • the patent US8147857 describes the production of a polyurethane gel as an antiseptic wound dressing.
  • the present invention relates to the use of a boron compound to enable the flexible polyurethane foam to gain wound-healing properties. Said document does not disclose the production of the polyurethane foam material.
  • the wound healing property of said polyurethane gel is not mentioned.
  • boron was added to a wide variety of materials. During this addition, boron is added to the foam by an impregnation method, but after this method, the foam loses its original property. The pores of the foam which is normally flexible, is an open cell foam and is air-permeable are closed after the boron impregnation, thus the permeability property is lost and the foam hardens. This technical problem in the state of the art needs to be overcome.
  • the object of the invention is to produce a composite material by adding boron to flexible polyurethane foam.
  • Said composite material is used in the fields such as medical, cleaning, mattress, upholstery (sofa), bras, and shoe insoles.
  • the composite material used for medical purposes is used to heal wounds.
  • the composite material formed by adding boron to the flexible polyurethane foam does not lose its flexible and air-permeable properties. Therefore, in foams which are normally flexible, are open cell foams and are air-permeable, the pores of the composite material obtained after the addition of a boron compound during the production of a base material are not closed, so the permeability is not lost and the foam does nor harden.
  • the amount of boron added to the material is important to have specific values. This value should be at least 40%.
  • Figure 1 is a schematic perspective view of a composite material according to the invention.
  • the invention relates to a composite material (1) formed by adding a boron compound (1.2) to a base material (1.1). Said composite material (1) will be used especially for medical purposes and has a wound healing property.
  • the composite material (1) of the invention includes a base material (1.1) and a boron compound (1.2) added to said base material (1.1) at a predetermined ratio.
  • Said base material (2) is flexible and is, but not limited to, a polyurethane material in a preferred embodiment of the invention.
  • the polyurethane material is preferably, but not limited to, a foam.
  • the boron compound (1.2) is added to the base material (1.1) during the production of the base material (1.1). Boron Compound (1.2) is not impregnated to Polyurethane base materials (1.1) in the state of the art with the invention. The boron compound (1.2) is added to the base material (1.1) during the production of the base material ( 1.1 ), so that a composite material (1) is obtained.
  • the pores of the base material (1.1) are formed during the production.
  • the particles of boron compound (1.2) incorporated in the production system are positioned around the pores. Therefore, the boron compound (1.2) does not cause any blockage in the pores.
  • the boron compound (1.1) is present in powder form, and the boron compound (1.2) is dispersed in the polyol and added to the base material (1.1).
  • the ratio of the boron compound (1.2) added to the base material (1.1) is 40% to 45%.
  • the composite material (1) of the invention has wound healing properties as well as antibacterial properties. It may also be used in all areas that require hygiene.
  • the mixture of polyol and boron compound (1.2) of equal amounts during production of polyurethane base material (1.1) is added to the production system.
  • the ratio of the boron compound (1.2) in the composite material (1) is allowed to be at least 40% by adding the mixture obtained with the addition of boron compound (1.2) of 50% to the polyol to the base material (1.1).
  • the pores are not blocked and the polyurethane base material (1.1) is not lost, as a result it does not harden, as the boron compound (1.2) is added to the system at this ratio during the production of the polyurethane base material (1.1).
  • Table 1 provides the content of the composite material (1) and the percentages by weight of the content. Table 1. Chemical content of the composite material (1) and the percentages by weight therefor
  • the composite material (1.1) contains 50% boron compound (wound healing agent) (1.2) in 80% to 90% by weight of poly ether polyol (raw material for polyurethane) and/or 0% to 5% by weight of methylene chloride (foaming agent) and/or 0.5% to 3% of water (raw material for foaming reaction) and/or 0.05% to 0.5 by weight of tin octoate (polyurethane catalyst) and/or 0.001 to 0.01 by weight of 70% bis (dimethyl amino ethyl) ether diluted in 30% propylene glycol (foaming catalyst) and/or 0.001% to 0.04% by weight of 33% triethylene diamine 67% dipropylene glycol solution (gelling catalyst) and/or 0% to 0.1% by weight of %33 urea solution (cross linker) and/or 0% to 0.1% by weight of diethanol amine/triethanolamine (cross linker) and/or 0.1% to 0.8% by weight of polyether modified polysi
  • borax pentahydrate (Etibor-48) (Na 2 B 4 0 7 .5H 2 0), or borax decahydrate (Na 2 B 4 O 7 .10H 2 O), or boric acid (Etidot-67) (H3BO3), or anhydrous borax (Etibor-68) (Na 2 B 4 0 ?
  • the boron compound (1.2) is suspended in the polyether polyol contained in the base material (1.1).
  • the above-mentioned boron compounds (1.2) are prepared by suspending in the polyol and the solution thereof contains 50% by weight of boron compound (1) and 50% by weight of polyether polyol.
  • the base material (El) contains 40 to 45% by weight of boron compound (1.2).
  • the composite material (1) has the ability to heal wounds.
  • the composite material (1) has a therapeutic effect, such as healing wounds on the skin.
  • the composite material is produced according to the following method (100) steps:
  • the second step adding 50% boron compound (wound healing agent) (1.2) in 80% to 90% by weight of polyether polyol (raw material for polyurethane) and/or 0% to 5% by weight of methylene chloride (foaming agent) and/or 0.5% to 3% of water (raw material for foaming reaction) and/or 0.05% to 0.5 by weight of tin octoate (polyurethane catalyst) and/or 0.001 to 0.01 by weight of 70% bis (dimethyl amino ethyl) ether diluted in 30% propylene glycol (foaming catalyst) and/or 0.001% to 0.04% by weight of 33% triethylene diamine 67% dipropylene glycol solution (gelling catalyst) and/or 0% to 0.1% by weight of %33 urea solution (cross linker) and/or 0% to 0.1% by weight of diethanol amine/triethanolamine (cross linker) and/or 0.1% to 0.8% by weight of polyether modified polysiloxane
  • the third step forming the composite material by a reaction of the materials from the mixer in a tunnel.
  • the composite material (1) of the invention will be used in the fields such as medical, cleaning, mattress, upholstery (sofa), bras, and shoe insoles.
  • the invention may be used in dressings, patient cleansing sponges, bandages, cleansing sponges, sickbeds, normal beds, products in contact with people (bra, shoe insole), etc.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP20735248.5A 2020-04-02 2020-05-28 Verbundstoff aus bor bei der herstellung eines polyurethanbasismaterials Pending EP4127043A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR202005248 2020-04-02
PCT/TR2020/050461 WO2021201792A1 (en) 2020-04-02 2020-05-28 A composite material formed by using boron during production of a polyurethane base material

Publications (1)

Publication Number Publication Date
EP4127043A1 true EP4127043A1 (de) 2023-02-08

Family

ID=71266784

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20735248.5A Pending EP4127043A1 (de) 2020-04-02 2020-05-28 Verbundstoff aus bor bei der herstellung eines polyurethanbasismaterials

Country Status (2)

Country Link
EP (1) EP4127043A1 (de)
WO (1) WO2021201792A1 (de)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10316156B3 (de) * 2003-04-09 2004-10-14 Beiersdorf Ag Antimikrobiell ausgerüstete Polymermaterialien und deren Verwendung als Wundauflage
JP2005154533A (ja) * 2003-11-25 2005-06-16 Nippon Polyurethane Ind Co Ltd 軟質ポリウレタンフォームの製造方法
FR2873300B1 (fr) * 2004-07-22 2007-03-09 Compart Sas Soc Par Actions Si Materiau coupe-feu
DE102004061406A1 (de) * 2004-12-21 2006-07-06 Bayer Innovation Gmbh Infektionsresistente Polyurethanschäume, Verfahren zu ihrer Herstellung und Verwendung in antiseptisch ausgestatteten Wundauflagen
EP1964580B1 (de) * 2007-03-01 2010-12-29 Mölnlycke Health Care AB Silberhaltige Schaumstruktur
ES2778375T3 (es) * 2013-04-08 2020-08-10 Univ Yeditepe Hidrogel a base de polímeros

Also Published As

Publication number Publication date
WO2021201792A1 (en) 2021-10-07

Similar Documents

Publication Publication Date Title
EP0934041B1 (de) Hydrogelwundverband und zugehöriges herstellungs- und benutzungsverfahren
EP1159972B1 (de) Metallverbindungen enthaltende antimikrobielle Wundauflagen
US6861067B2 (en) Hydrogel wound dressing and the method of making and using the same
US7538257B2 (en) Fluid wound dressing comprising partially cured polyurethane
KR101377569B1 (ko) 항균성 창상 피복재 및 그 제조방법
JP3345059B2 (ja) ポリウレタンフォームの製法
CN104667334B (zh) 一种含复合银锌抗菌材料的泡沫敷料及其制备方法
JP2875441B2 (ja) ポリウレタンフォームから成る包帯
JPH07113067B2 (ja) 親水性の発泡組成物
AU2007225574A1 (en) Methods for producing silver-bonded antimicrobial moist wound dressings and moist wound dressings produced by the methods
US20210023262A1 (en) Composition and dressing with nitric oxide
AU2003243262A1 (en) Hydrophilic foam compositions having antimicrobial properties
CN100536929C (zh) 一种医用敷料的制备方法
CN113456877B (zh) 有机硅泡沫医用敷料及其制备方法与应用
EP4127043A1 (de) Verbundstoff aus bor bei der herstellung eines polyurethanbasismaterials
CN109880052A (zh) 一种医用绷带涂覆用聚氨酯树脂复合料的制备方法
JPH07508429A (ja) 創傷用包帯,創傷用被覆物もしくはキャリアマトリックス
CN112266454A (zh) 一种端羟基聚合物在制备多功能聚氨酯软泡敷料中的应用
WO2007033135A2 (en) Process for manufacturing hemostatic agents and their uses
EP1558300A1 (de) Flüssiger wundverband aus teilweise gehärtetem polyurethan
EP4338762A1 (de) Verfahren zur herstellung einer hochabsorbierenden hydrogelzusammensetzung für medizinische zwecke, insbesondere für die wundbehandlung
JPS6244258A (ja) 医療用生体表面被覆材
AU2002251838B2 (en) Hydrogel wound dressing,preparation and use thereof
EP3850029A1 (de) Bormodifizierter flexibler polyurethanschaum für hygiene und verfahren zur herstellung davon
BRPI0903139A2 (pt) material interno para calçados e artefatos com zeólito de ìons de prata e processo de produção de material interno para calçados e artefatos

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220930

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SAFAS SAF PLASTIK SANAYI VE TICARET ANONIM SIRKETI

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)